These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 9774198

  • 21. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.
    Marais E, Genade S, Strijdom H, Moolman JA, Lochner A.
    J Mol Cell Cardiol; 2001 Dec; 33(12):2157-77. PubMed ID: 11735262
    [Abstract] [Full Text] [Related]

  • 22. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
    Weishaar RE, Quade MM, Schenden JA, Evans DB.
    J Cyclic Nucleotide Protein Phosphor Res; 1985 Dec; 10(6):551-64. PubMed ID: 3003170
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
    Murray F, MacLean MR, Pyne NJ.
    Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
    [Abstract] [Full Text] [Related]

  • 26. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P, Prigent AF, Lagarde M, Nemoz G.
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [Abstract] [Full Text] [Related]

  • 27. Nerve growth factor increases the cyclic GMP level and activates the cyclic GMP phosphodiesterase in PC12 cells.
    Laasberg T, Pihlak A, Neuman T, Paves H, Saarma M.
    FEBS Lett; 1988 Nov 07; 239(2):367-70. PubMed ID: 2460374
    [Abstract] [Full Text] [Related]

  • 28. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ, Cieslinski LB.
    Mol Pharmacol; 1990 Feb 07; 37(2):206-14. PubMed ID: 2154670
    [Abstract] [Full Text] [Related]

  • 29. Photoaffinity labelling of cyclic GMP-inhibited phosphodiesterase (PDE III) in human and rat platelets and rat tissues: effects of phosphodiesterase inhibitors.
    Tang KM, Jang EK, Haslam RJ.
    Eur J Pharmacol; 1994 Jun 15; 268(1):105-14. PubMed ID: 7925608
    [Abstract] [Full Text] [Related]

  • 30. A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases.
    Zhang KY, Card GL, Suzuki Y, Artis DR, Fong D, Gillette S, Hsieh D, Neiman J, West BL, Zhang C, Milburn MV, Kim SH, Schlessinger J, Bollag G.
    Mol Cell; 2004 Jul 23; 15(2):279-86. PubMed ID: 15260978
    [Abstract] [Full Text] [Related]

  • 31. Functional identification of phosphodiesterase activity in human trabecular meshwork cells.
    Zhou L, Thompson WJ, Potter DE.
    J Ocul Pharmacol Ther; 2000 Aug 23; 16(4):317-22. PubMed ID: 10977127
    [Abstract] [Full Text] [Related]

  • 32. Cyclic nucleotide phosphodiesterase activity in patients with obstructive airways disease.
    Polson JB, Krzanowski JJ, Goldman AL, Szentivanyi A.
    Allergol Immunopathol (Madr); 1982 Aug 23; 10(2):101-4. PubMed ID: 6125092
    [Abstract] [Full Text] [Related]

  • 33. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
    de Vente J, Markerink-van Ittersum M, Vles JS.
    J Chem Neuroanat; 2006 Jun 23; 31(4):275-303. PubMed ID: 16621445
    [Abstract] [Full Text] [Related]

  • 34. Selective alteration of Ca2+-dependent and Ca2+-independent cyclic nucleotide phosphodiesterase activity in rat cerebral cortex by cyclic nucleotides and their analogs.
    Davis CW.
    Biochim Biophys Acta; 1982 Jul 12; 705(1):1-7. PubMed ID: 6288105
    [Abstract] [Full Text] [Related]

  • 35. Cyclic nucleotide phosphodiesterase and aggregation in platelets from diabetic rats.
    Umeda F, Adnot S, Franks DJ, Hamet P.
    Metabolism; 1982 Jul 12; 31(7):704-9. PubMed ID: 6283306
    [Abstract] [Full Text] [Related]

  • 36. Role of phosphodiesterase in cyclic AMP signaling in cultured rat granulosa cells.
    Wang Z, Pan L, Luo J, Wang H, Shi F.
    Reprod Nutr Dev; 2006 Jul 12; 46(2):179-87. PubMed ID: 16597423
    [Abstract] [Full Text] [Related]

  • 37. [The role of the components of the cyclic nucleotide system in N-nitrosodiethylamine-induced hepatic carcinogenesis in rats].
    Antonenko SG, Berdinskikh NK, Mishnaevskaia EG.
    Eksp Onkol; 1990 Jul 12; 12(5):18-21. PubMed ID: 2171896
    [Abstract] [Full Text] [Related]

  • 38. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
    Kireeva NN, Bobruskin ID, Severin SE.
    Biokhimiia; 1995 May 12; 60(5):694-708. PubMed ID: 7662796
    [Abstract] [Full Text] [Related]

  • 39. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases.
    Kuo JF, Shoji M, Brackett NL, Helfman DM.
    J Cyclic Nucleotide Res; 1978 Dec 12; 4(6):463-74. PubMed ID: 85641
    [Abstract] [Full Text] [Related]

  • 40. Cyclic 3',5'-nucleotide phosphodiesterase activities in the thyroid glands of patients with various disorders.
    Nagasaka A, Hidaka H.
    J Clin Endocrinol Metab; 1980 Apr 12; 50(4):726-33. PubMed ID: 6245100
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.